会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • ISOLATED PHOSPHOLIPID-PROTEIN PARTICLES
    • 分离的磷脂 - 蛋白质颗粒
    • US20090161828A1
    • 2009-06-25
    • US12333191
    • 2008-12-11
    • Federico KatzenJulia FletcherWieslaw KudlickiJoseph BeechemLilin Wang
    • Federico KatzenJulia FletcherWieslaw KudlickiJoseph BeechemLilin Wang
    • G01N23/207C07K14/00C12N9/10C12N9/48C12N9/16
    • C12P21/02C07K1/02
    • Systems and methods are provided for producing a protein of interest that is typically not amenable to expression in soluble form in in vitro expression systems. In some aspects, the invention provides methods of synthesizing proteins using in vitro protein synthesis systems that include a scaffold protein such as apolipoprotein or an amphipathic alpha helix containing (“AAHC”) protein, in which higher yields of soluble protein are produced than in the absence of the scaffold protein. The scaffold proteins may be provided in an in vitro protein synthesis system associated with lipid or not associated with lipid. The scaffold protein may be provided as a protein per se or may be encoded by a nucleic acid template and co-expressed with the protein of interest. The invention also provides compositions and kits for synthesis of proteins in soluble form, in which the compositions and kits include cell extracts for protein expression and isolation.
    • 提供的系统和方法用于产生通常不适于在体外表达系统中以可溶形式表达的目的蛋白质。 在一些方面,本发明提供了使用体外蛋白质合成系统合成蛋白质的方法,所述体外蛋白质合成系统包括诸如载脂蛋白或含有(“AAHC”)蛋白质的两亲性α螺旋的支架蛋白,其中产生比在 缺少支架蛋白。 支架蛋白质可以提供在与脂质相关的体外蛋白质合成系统中或与脂质不相关。 支架蛋白质可以作为蛋白质本身提供,或者可以由核酸模板编码并与感兴趣的蛋白质共表达。 本发明还提供用于合成可溶形式的蛋白质的组合物和试剂盒,其中组合物和试剂盒包括用于蛋白质表达和分离的细胞提取物。
    • 2. 发明申请
    • ISOLATED PHOSPHOLIPID-PROTEIN PARTICLES
    • 分离的磷脂 - 蛋白质颗粒
    • US20100233782A1
    • 2010-09-16
    • US12576880
    • 2009-10-09
    • Federico KatzenJulia FletcherWieslaw KudlickiJoseph BeechemLilin Wang
    • Federico KatzenJulia FletcherWieslaw KudlickiJoseph BeechemLilin Wang
    • C12N9/10C07K14/00C12N9/48C12N9/16
    • C12P21/02C07K1/02
    • Systems and methods are provided for producing a protein of interest that is typically not amenable to expression in soluble form in in vitro expression systems. In some aspects, the invention provides methods of synthesizing proteins using in vitro protein synthesis systems that include a scaffold protein such as apolipoprotein or an amphipathic alpha helix containing (“AAHC”) protein, in which higher yields of soluble protein are produced than in the absence of the scaffold protein. The scaffold proteins may be provided in an in vitro protein synthesis system associated with lipid or not associated with lipid. The scaffold protein may be provided as a protein per se or may be encoded by a nucleic acid template and co-expressed with the protein of interest. The invention also provides compositions and kits for synthesis of proteins in soluble form, in which the compositions and kits include cell extracts for protein expression and isolation.
    • 提供的系统和方法用于产生通常不适于在体外表达系统中以可溶形式表达的目的蛋白质。 在一些方面,本发明提供了使用体外蛋白质合成系统合成蛋白质的方法,所述体外蛋白质合成系统包括诸如载脂蛋白或含有(“AAHC”)蛋白质的两亲性α螺旋的支架蛋白,其中产生比在 缺少支架蛋白。 支架蛋白质可以提供在与脂质相关的体外蛋白质合成系统中或与脂质不相关。 支架蛋白质可以作为蛋白质本身提供,或者可以由核酸模板编码并与感兴趣的蛋白质共表达。 本发明还提供用于合成可溶形式的蛋白质的组合物和试剂盒,其中组合物和试剂盒包括用于蛋白质表达和分离的细胞提取物。
    • 3. 发明申请
    • ISOLATED PHOSPHOLIPID-PROTEIN PARTICLES
    • 分离的磷脂 - 蛋白质颗粒
    • US20080248565A1
    • 2008-10-09
    • US12040798
    • 2008-02-29
    • Federico KatzenJulia FletcherWieslaw KudlickiJoseph BeechemLilin Wang
    • Federico KatzenJulia FletcherWieslaw KudlickiJoseph BeechemLilin Wang
    • C12N5/06C07K14/00
    • C12P21/02C07K1/02
    • Systems and methods are provided for producing a protein of interest that is typically not amenable to expression in soluble form in in vitro expression systems. In some aspects, the invention provides methods of synthesizing proteins using in vitro protein synthesis systems that include a scaffold protein such as apolipoprotein or an amphipathic alpha helix containing (“AAHC”) protein, in which higher yields of soluble protein are produced than in the absence of the scaffold protein. The scaffold proteins may be provided in an in vitro protein synthesis system associated with lipid or not associated with lipid. The scaffold protein may be provided as a protein per se or may be encoded by a nucleic acid template and co-expressed with the protein of interest. The invention also provides compositions and kits for synthesis of proteins in soluble form, in which the compositions and kits include cell extracts for protein expression and isolation.
    • 提供的系统和方法用于产生通常不适于在体外表达系统中以可溶形式表达的目的蛋白质。 在一些方面,本发明提供了使用体外蛋白质合成系统合成蛋白质的方法,所述体外蛋白质合成系统包括诸如载脂蛋白或含有(“AAHC”)蛋白质的两亲性α螺旋的支架蛋白,其中产生比在 缺少支架蛋白。 支架蛋白质可以提供在与脂质相关的体外蛋白质合成系统中或与脂质不相关。 支架蛋白质可以作为蛋白质本身提供,或者可以由核酸模板编码并与感兴趣的蛋白质共表达。 本发明还提供用于合成可溶形式的蛋白质的组合物和试剂盒,其中组合物和试剂盒包括用于蛋白质表达和分离的细胞提取物。
    • 4. 发明申请
    • Products and processes for in vitro synthesis of biomolecules
    • 用于体外合成生物分子的产物和方法
    • US20060211083A1
    • 2006-09-21
    • US11336644
    • 2006-01-20
    • Federico KatzenWieslaw KudlickiJulia Fletcher
    • Federico KatzenWieslaw KudlickiJulia Fletcher
    • C12P21/06C07K14/47
    • C12P19/34C12P21/005
    • Provided herein are products and processes for efficiently synthesizing biomolecules in vitro using cell-free extracts derived from mammalian cells and insect cells. In an embodiment, provided is a process for preparing a cell-free extract from insect cells and mammalian cells that efficiently synthesizes post-translationally modified target proteins (e.g., glycosylated target proteins). In some embodiments, a ribonucleic acid is synthesized in vitro that comprises a cap, a 5′ untranslated region comprising an 18S rRNA binding ribonucleotide sequence, and a target ribonucleotide sequence. It has been determined that such ribonucleic acids result in efficient in vitro synthesis of a target protein using cell-free extracts derived from non-rabbit mammalian cells and insect cells.
    • 本文提供了使用来自哺乳动物细胞和昆虫细胞的无细胞提取物在体外有效合成生物分子的产物和方法。 在一个实施方案中,提供了从昆虫细胞和哺乳动物细胞制备无细胞提取物的方法,其有效合成翻译后修饰的靶蛋白(例如糖基化靶蛋白)。 在一些实施方案中,在体外合成核糖核酸,其包含帽,包含18S rRNA结合核糖核苷酸序列的5'非翻译区和靶核糖核苷酸序列。 已经确定,使用来自非兔哺乳动物细胞和昆虫细胞的无细胞提取物,这种核糖核酸导致靶蛋白的有效体外合成。
    • 7. 发明申请
    • IN VITRO PROTEIN SYNTHESIS SYSTEMS FOR MEMBRANE PROTEINS THAT INCLUDE ADOLIPOPROTEINS AND PHOSPHOLIPID-ADOLIPOPROTEIN PARTICLES
    • 用于含有ADOLIPOPROTEINS和磷脂 - ADOLIPOPROTEIN颗粒的膜蛋白的体外蛋白合成系统
    • US20070117179A1
    • 2007-05-24
    • US11535960
    • 2006-09-27
    • Wieslaw KudlickiJulia FletcherFederico Katzen
    • Wieslaw KudlickiJulia FletcherFederico Katzen
    • C12P21/06
    • C12P21/00
    • In vitro protein synthesis systems and methods are provided that produce membrane proteins in soluble form. In some aspects, the invention provides methods of synthesizing proteins using in vitro protein synthesis systems that include an apolipoprotein, in which higher yields of soluble protein are produced than in the absence of the apolipoprotein. Apolipoproteins useful in the present invention include naturally occurring apolipoproteins, as well as sequence variants of wild-type apolipoproteins, and engineered apolipoproteins. The apolipoproteins can be provided in an in vitro protein synthesis system associated with lipid or not associated with lipid. The invention also provides compositions and kits for synthesis of proteins in soluble form, in which the compositions and kits include cell extracts for protein translation and at least one apolipoprotein biomolecule.
    • 提供体外蛋白质合成系统和方法,其产生可溶形式的膜蛋白质。 在一些方面,本发明提供使用体外蛋白质合成系统合成蛋白质的方法,所述体外蛋白质合成系统包括与不存在载脂蛋白时产生更高产率的可溶性蛋白质的载脂蛋白。 可用于本发明的载脂蛋白包括天然存在的载脂蛋白,以及野生型载脂蛋白和工程化载脂蛋白的序列变体。 载脂蛋白可以在与脂质相关的体外蛋白质合成系统中提供,或与脂质不相关。 本发明还提供用于合成可溶形式的蛋白质的组合物和试剂盒,其中组合物和试剂盒包括用于蛋白质翻译的细胞提取物和至少一种载脂蛋白生物分子。
    • 9. 发明授权
    • Method of synthesizing a fluorescently labeled protein
    • 合成荧光标记蛋白的方法
    • US06448033B1
    • 2002-09-10
    • US08590729
    • 1996-01-24
    • Wieslaw KudlickiGisela KramerBoyd Hardesty
    • Wieslaw KudlickiGisela KramerBoyd Hardesty
    • C12P2106
    • C07K1/1077C12N9/10C12P21/02G01N33/533
    • The present invention provides a method of synthesizing a fluorescently labeled protein in a cell free protein synthesis system, comprising the steps of: (a) incubating a sample of ribosomes obtained from a cell-free extract with plasmid DNA containing a coding sequence for a protein of interest, said sample incubated in a coupled transcription/translation medium together with a aminoacyl tRNA having fluorescent label; (b) partially purifying said fluorescently labeled protein by separating newly synthesized, fluorescently-labeled protein from other fluorescent components within said sample; (c) measuring the amount of protein synthesized; (d) determining fluorescence of newly synthesized protein; and (e) determining the biological activity of the newly synthesized protein.
    • 本发明提供了一种在无细胞蛋白质合成系统中合成荧光标记的蛋白质的方法,包括以下步骤:(a)将从无细胞提取物获得的核糖体样品与含有蛋白质编码序列的质粒DNA 所述样品与偶联的转录/翻译培养基一起孵育,同时具有荧光标记的氨酰基tRNA; (b)通过将新合成的荧光标记的蛋白质与所述样品中的其他荧光成分分离,部分纯化所述荧光标记的蛋白质; (c)测量合成的蛋白质的量; (d)确定新合成的蛋白质的荧光; 和(e)确定新合成的蛋白质的生物活性。